欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
SE/H/0933/002
药品名称
Optava
活性成分
carmellose 5.0 mg/ml
剂型
Eye drops, solution
上市许可持有人
Allergan Pharmaceuticals Ireland
参考成员国 - 产品名称
Sweden (SE)
Optava
互认成员国 - 产品名称
许可日期
2010/12/15
最近更新日期
2015/01/02
药物ATC编码
S01XA20 artificial tears and other indifferent preparations
申请类型
TypeLevel1:
Known Active Substance
TypeLevel2:
Additional Strength/Form
TypeLevel3:
Full Dossier Art 8.3(i) Dir 2001/83/EC
TypeLevel4:
Chemical Substance
TypeLevel5:
Prescription Only
附件文件下载
Final PL
|
SE_H_0933_002_Final PL
Date of last change:2024/09/06
Final SPC
|
SE_H_0933_002_Final SPC
Date of last change:2024/09/06
PubAR
|
SE_H_0933_002_PAR
Date of last change:2024/09/06
市场状态
Withdrawn(注:已撤市)
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase